SCHEMBL119672

SCHEMBL119672

COC(=O)c1ccc(S(=O)(=O)NCc2ccc(Oc3ccccc3)cc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.70
TSHR P16473 1/20 0.65
ALDH1A1 P00352 3/20 0.61
NAMPT P43490 1/20 0.55
OPRK1 P41145 4/20 0.54
ADAMTS4 O75173 2/20 0.54
MMP2 P08253 2/20 0.54
MMP13 P45452 2/20 0.54
MMP14 P50281 2/20 0.54
ADAMTS5 Q9UNA0 2/20 0.54
MMP1 P03956 1/20 0.54
MEP1B Q16820 1/20 0.54
GPR55 Q9Y2T6 1/20 0.53
MAPT P10636 3/20 0.52
LMNA P02545 1/20 0.52
HPGD P15428 1/20 0.52
KMT2A Q03164 1/20 0.52
OPRM1 P35372 2/20 0.52
CA12 O43570 2/20 0.51
CA9 Q16790 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119461 0.90 POLB (0.72) POLBTSHRALDH1A1NAMPTOPRK1
SCHEMBL3850206 0.90 POLB (0.72) POLBTSHRALDH1A1NAMPTMAPT
SCHEMBL20981395 0.87 TSHR (0.80) POLBTSHRALDH1A1NAMPTOPRK1
SCHEMBL1278961 0.87 TSHR (0.80) POLBTSHRALDH1A1NAMPTOPRK1
SCHEMBL20981410 0.83 ALDH1A1 (0.68) POLBTSHRALDH1A1NAMPTMAPT
SCHEMBL1287354 0.82 POLB (0.65) POLBTSHRALDH1A1NAMPTMAPT
SCHEMBL1169525 0.82 POLB (0.65) POLBTSHRALDH1A1NAMPTMAPT
SCHEMBL7776449 0.80 MAPT (0.64) TSHRMAPTKMT2ARAB9ACA1
SCHEMBL5608453 0.79 MAPT (0.71) POLBTSHRALDH1A1MMP1MAPT
SCHEMBL9242690 0.79 MAPT (0.71) POLBTSHRALDH1A1MMP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102427810-A Sulfamoylbenzoic acid derivatives as TRPM8 antagonists RAQUALIA PHARMA INC 2012-04-25 CN disclosed
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
EP-2424517-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RaQualia Pharma Inc (JP) 2012-03-07 EP disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 POLB 4630/4885TSHR 1240/4885ALDH1A1 1996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.